Showing results (101-110 of 905) with videos related to
Sort By:
Pageof 91
European Journal of Heart Failure|January 17, 2020
Predictors of sudden cardiac death in high-risk patients following a myocardial infarctionKieran F Docherty, João Pedro Ferreira, Abhinav Sharma, et al.Circulation|May 8, 2002
Mineralocorticoid receptor antagonism in experimental atherosclerosisSanjay Rajagopalan, Damon Duquaine, Steven King, et al.The American Journal of Cardiology|February 25, 2012
Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study)Bertram Pitt, Joseph Loscalzo, John Monyak, et al.Journal of Cardiac Failure|May 9, 2006
Spironolactone treatment and clinical outcomes in patients with systolic dysfunction and mild heart failure symptoms: a retrospective analysisRagavendra R Baliga, Prathiba Ranganna, Bertram Pitt, et al.Circulation|September 28, 2005
Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertensionWilliam B White, Bertram Pitt, Richard A Preston, et al.Cardiovascular Drugs and Therapy|November 9, 2021
The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes MellitusBertram Pitt, Gabriel Steg, Lawrence A Leiter, et al.American Heart Journal|December 6, 2011
Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fractionAkshay S Desai, Eldrin F Lewis, Rebecca Li, et al.European Journal of Heart Failure|October 28, 2022
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trialsJoão Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.Circulation. Heart Failure|March 16, 2019
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation StatusSøren L Kristensen, Ulrik M Mogensen, Pardeep S Jhund, et al.Circulation Research|May 24, 2019
Heart Failure With Preserved Ejection Fraction In PerspectiveMarc A Pfeffer, Amil M Shah, Barry A BorlaugPageof 91